Cargando…

Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach

BACKGROUND: Autoimmune-mediated encephalitis is a disease that often encompasses psychiatric symptoms as its first clinical manifestation’s predominant and isolated characteristic. Novel guidelines even distinguish autoimmune psychosis from autoimmune encephalitis. The aim of this review is thus to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Niels, Lipp, Michael, Vogelgsang, Jonathan, Vukovich, Ruth, Zindler, Tristan, Luedecke, Daniel, Gingele, Stefan, Malchow, Berend, Frieling, Helge, Kühn, Simone, Denk, Johannes, Gallinat, Jürgen, Skripuletz, Thomas, Moschny, Nicole, Fiehler, Jens, Riedel, Christian, Wiedemann, Klaus, Wattjes, Mike P., Zerr, Inga, Esselmann, Hermann, Bleich, Stefan, Wiltfang, Jens, Neyazi, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474611/ https://www.ncbi.nlm.nih.gov/pubmed/34589896 http://dx.doi.org/10.1016/j.bbih.2020.100154

Ejemplares similares

Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry
por: Hansen, Niels, et al.
Publicado: (2021)

Simulating ComBat: how batch correction can lead to the systematic introduction of false positive results in DNA methylation microarray studies
por: Zindler, Tristan, et al.
Publicado: (2020)

Novel candidate genes for ECT response prediction—a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy
por: Moschny, Nicole, et al.
Publicado: (2020)

Epinephrine levels decrease in responders after electroconvulsive therapy
por: Pollak, Christoph, et al.
Publicado: (2021)

Higher Level of Mismatch in APOE ε4 Carriers for Amyloid-Beta Peptide Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid
por: Vogelgsang, Jonathan, et al.
Publicado: (2019)

DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy
por: Maier, Hannah B., et al.
Publicado: (2023)

Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review
por: Hansen, Niels, et al.
Publicado: (2022)

Acute Enterovirus Encephalitis as a Cause for Isolated Visual and Auditory Hallucinations in a 22-Year-Old Patient
por: Deest, M., et al.
Publicado: (2021)

DNA Methylation of the t-PA Gene Differs Between Various Immune Cell Subtypes Isolated From Depressed Patients Receiving Electroconvulsive Therapy
por: Moschny, Nicole, et al.
Publicado: (2020)

Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort
por: Hansen, Niels, et al.
Publicado: (2021)

S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study
por: Maier, Hannah, et al.
Publicado: (2018)

Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients
por: Maier, Hannah Benedictine, et al.
Publicado: (2022)

Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study
por: Toto, Sermin, et al.
Publicado: (2019)

Catatonic Schizophrenia Associated With Cerebrospinal GAD65 Autoantibodies: Case Report and Literature Review
por: Hansen, Niels, et al.
Publicado: (2022)

Case Report: Alzheimer's Dementia Associated With Cerebrospinal Fluid Neurochondrin Autoantibodies
por: Hansen, Niels, et al.
Publicado: (2022)

Immunotherapy with corticosteroids in anti-neural autoantibody-associated cognitive impairment: Retrospective case series
por: Hansen, Niels, et al.
Publicado: (2022)

Long-Term Course of Neural Autoantibody-Associated Psychiatric Disorders: Retrospective Data from a Specifically Immunopsychiatric Outpatient Clinic
por: Hansen, Niels, et al.
Publicado: (2023)

Neurological soft signs are increased in major depressive disorder irrespective of treatment
por: Schülke, Rasmus, et al.
Publicado: (2023)

Alzheimer’s disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C
por: Konen, Franz Felix, et al.
Publicado: (2023)

Role of CD20(+) T cells in multiple sclerosis: implications for treatment with ocrelizumab
por: Gingele, Stefan, et al.
Publicado: (2019)

BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response
por: Lieb, Klaus, et al.
Publicado: (2018)

Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
por: Hansen, Niels, et al.
Publicado: (2020)

Corrigendum: Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
por: Hansen, Niels, et al.
Publicado: (2020)

Case report: Anti-CARPVIII autoantibody-associated mixed dementia
por: Hansen, Niels, et al.
Publicado: (2023)

Persisting Verbal Memory Encoding and Recall Deficiency after mGluR5 Autoantibody-Mediated Encephalitis
por: Hansen, Niels, et al.
Publicado: (2023)

Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
por: Gudi, Viktoria, et al.
Publicado: (2014)

P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy
por: Neyazi, Alexandra, et al.
Publicado: (2018)

Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditions
por: Gingele, Stefan, et al.
Publicado: (2021)

DNA methylation results depend on DNA integrity—role of post mortem interval
por: Rhein, Mathias, et al.
Publicado: (2015)

Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation
por: Klafki, Hans-W., et al.
Publicado: (2022)

Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination
por: Gudi, Viktoria, et al.
Publicado: (2021)

Reproducibility of Alzheimer’s Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions
por: Vogelgsang, Jonathan, et al.
Publicado: (2018)

CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease
por: Teuber-Hanselmann, Sarah, et al.
Publicado: (2020)

Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer’s Disease
por: Hermann, Peter, et al.
Publicado: (2022)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

Psychiatric Symptoms in Patients with Shiga Toxin-Producing E. coli O104:H4 Induced Haemolytic-Uraemic Syndrome
por: Kleimann, Alexandra, et al.
Publicado: (2014)

Short Communication: Interaction of Nerve Growth Factor (NGF) and Vascular Endothelial Growth Factor (VEGF) in Healthy Individuals
por: Groh, Adrian, et al.
Publicado: (2019)

Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia
por: Bibl, Mirko, et al.
Publicado: (2010)

The association of body mass index and body composition with plasma amyloid beta levels
por: Hermesdorf, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nc3d2eiu4eik6h09qdlgaoj70a